Fibromyalgia Syndrome (FMS) is a complex chronic pain disorder characterized by widespread pain associated with numerous symptoms. It is more common in women over 50 years of age with low educational and socioeconomic status living in rural areas. Pain Science Education (PSE) is one of the most widely used treatments for chronic pain management. This treatment consists of an educational intervention aimed at reconceptualizing and modifying erroneous cognitions regarding pain in these patients. The objective of this study is to evaluate the effectiveness of PSE in patients with FMS living in rural areas. They will be randomly assigned to one of two treatment groups. The intervention group will receive two adapted in-person sessions (90 minutes per session/week) by a therapist experienced in teaching PSE. The control group will begin the conventional treatment they received before participating in the study. After the end of the study, patients in the control group will be given their intervention group records. The variables measured will include the impact of FMS on daily life, pain sensitivity, central sensitization, pain catastrophizing, fear of movement, anxiety and depression, self-efficacy, and assessment of knowledge and beliefs about PSE. Assessments will be conducted before the intervention, after the second PSE session, and three months later by the same researcher.
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Pain sensitivity
Timeframe: All outcomes will be measured at the beginning of the study, at the end of all PSE sessions, and at the three-month follow-up.
Impact of FMS on daily life
Timeframe: All outcomes will be measured at the beginning of the study, at the end of all PSE sessions, and at the three-month follow-up.
Central sensitization
Timeframe: All outcomes will be measured at the beginning of the study, at the end of all PSE sessions, and at the three-month follow-up.
Pain catastrophizing
Timeframe: All outcomes will be measured at the beginning of the study, at the end of all PSE sessions, and at the three-month follow-up.
Fear of Movement
Timeframe: All outcomes will be measured at the beginning of the study, at the end of all PSE sessions, and at the three-month follow-up.
Anxiety and depression
Timeframe: All outcomes will be measured at the beginning of the study, at the end of all PSE sessions, and at the three-month follow-up.
Self-efficacy
Timeframe: All outcomes will be measured at the beginning of the study, at the end of all PSE sessions, and at the three-month follow-up.
Knowledge and beliefs about PSE
Timeframe: All outcomes will be measured at the beginning of the study, at the end of all PSE sessions, and at the three-month follow-up.